Clinical Trial: Aflibercept for Diabetic Macular Edema In Real-life Practice in GREece
Study Status: Completed
Recruit Status: Completed
Condition: Diabetic Macular Edema
Study Type: Observational
Official Title: Aflibercept for Diabetic Macular Edema In Real-life Practice in GREece: The ADMIRE Study
Brief Summary:
ADMIRE was a prospective, observational cohort study of patients with diabetic macular edema (DME). Efficacy was assessed by change in best-corrected visual acuity (BCVA) and central retinal thickness (CRT) from baseline to months 12, 24 and 36 after treatment with intravitreal aflibercept in treatment-naïve patients and previously treated patients. Safety was evaluated by recording any patients-reported events.
Read more